ARDS Caused by COVID-19

Main Features and Ventilatory Management of Patients With ARDS Caused by COVID-19

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04368975

Enrollment

500

Registered

2020-04-30

Start date

2020-03-12

Completion date

2020-12-31

Last updated

2020-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure With Hypoxia

Brief summary

Patients with the acute respiratory distress syndrome (ARDS) have markedly varied clinical presentations. Main characteristics of mechanically ventilated ARDS caused by COVID-19, and adherence to lung-protective ventilation strategies are not well known.

Detailed description

This is a multicenter, prospective, observational study in consecutive, mechanically ventilated patients with ARDS caused by COVID-19 (as defined by the Berlin criteria and confirmed COVID-19 infection in a respiratory tract sample), admitted into a network of 27 Spanish and Andorran intensive care units (ICUs). Clinical features, ventilatory management, and clinical outcomes will be examined

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* aged 18 years or older * intubated and mechanically ventilated * confirmed COVID-19 infection in a respiratory tract sample * acute onset of ARDS, as defined by the Berlin criteria

Exclusion criteria

* patients with non-confirmed SARS-CoV-2 infection according to WHO guidance * patients with no information on respiratory parameters * non- intubated patients

Design outcomes

Primary

Measure	Time frame
Discontinuation from mechanical ventilation	28 days

Countries

Spain

Contacts

Primary ContactCarlos Ferrando, PhD

cmferrando@clinic.cat609892732

Backup ContactSara Darriba, PhD

darriba@clinic.cat

Outcome results